New York, United States, 2022-Jun-10 — /EPR Network/ — The Immune Checkpoint Inhibitors Market is expected to be worth US$ 35 Bn by the year 2028, at a CAGR of 14.6% between [read full press release…]
New York, United States, 2022-Apr-20 — /EPR Network/ — The Immune Repertoire Sequencing Market is likely to grow voraciously, i.e. at a CAGR of 7.3% between 2018-2026,. Augmented and virtual [read full press release…]
New York, United States, 2022-Apr-08 — /EPR Network/ — The Immune Repertoire Sequencing Market is slated to grow on a stellar note going forward. The [read full press release…]
New York, United States, 2022-Apr-07 — /EPR Network/ — The Immune Repertoire Sequencing Market is bound to witness a CAGR of 7.3% and 2X between [read full press release…]
Albany, US, 2018-Jun-11 — /EPR Network/ —Proliferated use of hematopoietic stem cell transplantation as a potent treatment for cancer and numerous autoimmune diseases has resulted [read full press release…]
